APAC Region to Grow at the Highest Growth Rate in Ocular Implants Market

As stated by a market research firm, P&S Intelligence, the total revenue generated by the ocular implants industry USD 10,079.7 million in 2021, and it will power at a rate of 6.2% in the years to come, to reach USD 17,279.4 million by 2030. 

Ocular diagnostic technology progressions have led to an increased product uptake. These new techs are helping improve results for eye surgeries and open up novel ways of seeing for blinds. 

Therefore, the increasing acceptance of advanced ocular equipment, for example bionic and artificial eyes and glaucoma devices, has created more than a few prospects for industry players.

A cataract is an eye infection characterized by clouding of the lens of the eye, the sternness of which can result in vision loss. As cataract is a major cause of impaired vision, the category had the largest share, of over 45%, in 2021. 

As said by a government report, about 65.2 million people were affected by cataracts in the year 2021.

Hospitals dominated the industry, and it will witness a healthy rate, of over 6%, in the years to come. This is mainly because of the fact that hospitals are large healthcare establishments that deliver a number of specialist treatments under one roof, and they have accomplished ocular practitioners and seen increased patient footfall. 

Furthermore, specialty eye institutes had a significant share, because of the growing count of these institutes and ophthalmologists in emerging nations, as well as Thailand, India the Philippines, and China, because of the favorable policies of the government and increased ease of doing business in these nations.

APAC ocular implants market will register the highest rate, of over 6%, with regards to revenue, in the years to come. There is a large pool of old people in APAC nations who are sensitive to lasting diseases, such as diabetes and are at a high risk of obtaining severe eye disorders.

Moreover, the North America generated a momentous revenue in the recent past. This is as a result of the presence of important players and a surge in the eye procedures count in the region. 

Furthermore, regional companies are concentrating their efforts on both emerging and advanced regions, for taking advantage of all unexplored projections. 

The U.S. is the leader of the North American market. Key players in the nation are laying emphasis on product approvals and introductions of cutting-edge ocular implants. 

It is because of the increasing cases of ophthalmologic diseases, and the rising awareness of comprehensive eye care settings, the demand for ocular implants will continue to grow in the years to come.

Report this Page